Novartis prevails on appeal, keeping Entresto generics at bay – FirstWord Pharma
Novartis prevails on appeal, keeping Entresto generics at bay FirstWord Pharma
In: PATENT NEWS
Novartis prevails on appeal, keeping Entresto generics at bay FirstWord Pharma
In: PATENT NEWS
According to one of Inari’s petitions to the acting director, one of the PTAB denials “raises an important question of law and patent policy.” In …
In: PATENT NEWS
Acting USPTO Chief Won’t Review Seed IP Challenge Denial Law360
In: PATENT NEWS
… patent law and appellate experience to support our clients’ groundbreaking work.” Geoff Moss. Geoff is an IP litigator based in Los Angeles. Before …
In: PATENT NEWS
“With a strong foundation in both science and law, Carl’s highly impressive work in securing, protecting, and managing patent rights for clients …
In: PATENT NEWS
Goodwin Proctor Adds NY IP Attys From Fenwick, Desmarais Law360
In: TRADEMARK NEWS
Mars Wrigley alleges cannabis company in violation of Skittles trademark agreement Green Market Report
In: PATENT NEWS
Case: Patents/Pleadings (D. Del.) … The court denied Apotex’s motion seeking judgment of no induced infringement as a matter of law, and granted its …
In: PATENT NEWS
Case: Patents/Obviousness (Fed. Cir.) The Federal Circuit affirmed the decision of the Patent Trial and Appeal Board …
In: TRADEMARK NEWS
Texas Jury Rules in Favor of Austin Whiskey Company in Trademark Dispute USA Herald
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION